Literature DB >> 17475247

ArPIKfyve-PIKfyve interaction and role in insulin-regulated GLUT4 translocation and glucose transport in 3T3-L1 adipocytes.

Ognian C Ikonomov1, Diego Sbrissa, Rajeswari Dondapati, Assia Shisheva.   

Abstract

Insulin activates glucose transport by promoting translocation of the insulin-sensitive fat/muscle-specific glucose transporter GLUT4 from an intracellular storage compartment to the cell surface. Here we report that an optimal insulin effect on glucose uptake in 3T3-L1 adipocytes is dependent upon expression of both PIKfyve, the sole enzyme for PtdIns 3,5-P(2) biosynthesis, and the PIKfyve activator, ArPIKfyve. Small-interfering RNAs that selectively ablated PIKfyve or ArPIKfyve in this cell type depleted the PtdIns 3,5-P(2) pool and reduced insulin-activated glucose uptake to a comparable degree. Combined loss of PIKfyve and ArPIKfyve caused further PtdIns 3,5-P(2) ablation that correlated with greater attenuation in insulin responsiveness. Loss of PIKfyve-ArPIKfyve reduced insulin-stimulated Akt phosphorylation and the cell surface accumulation of GLUT4 or IRAP, but not GLUT1-containing vesicles without affecting overall expression of these proteins. ArPIKfyve and PIKfyve were found to physically associate in 3T3-L1 adipocytes and this was insulin independent. In vitro labeling of membranes isolated from basal or insulin-stimulated 3T3-L1 adipocytes documented substantial insulin-dependent increases of PtdIns 3,5-P(2) production on intracellular membranes. Together, the data demonstrate for the first time a physical association between functionally related PIKfyve and ArPIKfyve in 3T3-L1 adipocytes and indicate that the novel ArPIKfyve-PIKfyve-PtdIns 3,5-P(2) pathway is physiologically linked to insulin-activated GLUT4 translocation and glucose transport.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17475247      PMCID: PMC2475679          DOI: 10.1016/j.yexcr.2007.03.024

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  46 in total

1.  Ent5p is required with Ent3p and Vps27p for ubiquitin-dependent protein sorting into the multivesicular body.

Authors:  Anne Eugster; Eve-Isabelle Pécheur; Fabrice Michel; Barbara Winsor; François Letourneur; Sylvie Friant
Journal:  Mol Biol Cell       Date:  2004-04-23       Impact factor: 4.138

Review 2.  Regulated membrane trafficking of the insulin-responsive glucose transporter 4 in adipocytes.

Authors:  Robert T Watson; Makoto Kanzaki; Jeffrey E Pessin
Journal:  Endocr Rev       Date:  2004-04       Impact factor: 19.871

3.  PIKfyve controls fluid phase endocytosis but not recycling/degradation of endocytosed receptors or sorting of procathepsin D by regulating multivesicular body morphogenesis.

Authors:  Ognian C Ikonomov; Diego Sbrissa; Michelangelo Foti; Jean-Louis Carpentier; Assia Shisheva
Journal:  Mol Biol Cell       Date:  2003-08-07       Impact factor: 4.138

4.  Svp1p defines a family of phosphatidylinositol 3,5-bisphosphate effectors.

Authors:  Stephen K Dove; Robert C Piper; Robert K McEwen; Jong W Yu; Megan C King; David C Hughes; Jan Thuring; Andrew B Holmes; Frank T Cooke; Robert H Michell; Peter J Parker; Mark A Lemmon
Journal:  EMBO J       Date:  2004-04-22       Impact factor: 11.598

5.  Increased insulin sensitivity and reduced adiposity in phosphatidylinositol 5-phosphate 4-kinase beta-/- mice.

Authors:  Katja A Lamia; Odile D Peroni; Young-Bum Kim; Lucia E Rameh; Barbara B Kahn; Lewis C Cantley
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

6.  Myotubularin regulates the function of the late endosome through the gram domain-phosphatidylinositol 3,5-bisphosphate interaction.

Authors:  Kazuya Tsujita; Toshiki Itoh; Takeshi Ijuin; Akitsugu Yamamoto; Assia Shisheva; Jocelyn Laporte; Tadaomi Takenawa
Journal:  J Biol Chem       Date:  2004-01-12       Impact factor: 5.157

7.  The phosphatidylinositol (PI)-5-phosphate 4-kinase type II enzyme controls insulin signaling by regulating PI-3,4,5-trisphosphate degradation.

Authors:  Valerie Carricaburu; Katja A Lamia; Elizabeth Lo; Laetitia Favereaux; Bernard Payrastre; Lewis C Cantley; Lucia E Rameh
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-01       Impact factor: 11.205

8.  Active PIKfyve associates with and promotes the membrane attachment of the late endosome-to-trans-Golgi network transport factor Rab9 effector p40.

Authors:  Ognian C Ikonomov; Diego Sbrissa; Krzysztof Mlak; Robert Deeb; Jason Fligger; Aleric Soans; Russell L Finley; Assia Shisheva
Journal:  J Biol Chem       Date:  2003-10-06       Impact factor: 5.157

Review 9.  Regulating Glut4 vesicle dynamics by phosphoinositide kinases and phosphoinositide phosphatases.

Authors:  Assia Shisheva
Journal:  Front Biosci       Date:  2003-09-01

10.  Vacuole size control: regulation of PtdIns(3,5)P2 levels by the vacuole-associated Vac14-Fig4 complex, a PtdIns(3,5)P2-specific phosphatase.

Authors:  Simon A Rudge; Deborah M Anderson; Scott D Emr
Journal:  Mol Biol Cell       Date:  2003-10-03       Impact factor: 4.138

View more
  24 in total

Review 1.  PIKfyve: Partners, significance, debates and paradoxes.

Authors:  Assia Shisheva
Journal:  Cell Biol Int       Date:  2008-01-25       Impact factor: 3.612

2.  Kinesin adapter JLP links PIKfyve to microtubule-based endosome-to-trans-Golgi network traffic of furin.

Authors:  Ognian C Ikonomov; Jason Fligger; Diego Sbrissa; Rajeswari Dondapati; Krzysztof Mlak; Robert Deeb; Assia Shisheva
Journal:  J Biol Chem       Date:  2008-12-04       Impact factor: 5.157

3.  The nucleophosmin-anaplastic lymphoma kinase oncogene interacts, activates, and uses the kinase PIKfyve to increase invasiveness.

Authors:  Sophie Dupuis-Coronas; Frédéric Lagarrigue; Damien Ramel; Gaëtan Chicanne; Estelle Saland; Frédérique Gaits-Iacovoni; Bernard Payrastre; Hélène Tronchère
Journal:  J Biol Chem       Date:  2011-07-07       Impact factor: 5.157

4.  Functional dissociation between PIKfyve-synthesized PtdIns5P and PtdIns(3,5)P2 by means of the PIKfyve inhibitor YM201636.

Authors:  Diego Sbrissa; Ognian C Ikonomov; Catherine Filios; Khortnal Delvecchio; Assia Shisheva
Journal:  Am J Physiol Cell Physiol       Date:  2012-05-23       Impact factor: 4.249

Review 5.  Small molecule adenosine 5'-monophosphate activated protein kinase (AMPK) modulators and human diseases.

Authors:  Sandeep Rana; Elizabeth C Blowers; Amarnath Natarajan
Journal:  J Med Chem       Date:  2014-08-28       Impact factor: 7.446

6.  Plentiful PtdIns5P from scanty PtdIns(3,5)P2 or from ample PtdIns? PIKfyve-dependent models: Evidence and speculation (response to: DOI 10.1002/bies.201300012).

Authors:  Assia Shisheva; Diego Sbrissa; Ognian Ikonomov
Journal:  Bioessays       Date:  2014-11-18       Impact factor: 4.345

7.  ArPIKfyve homomeric and heteromeric interactions scaffold PIKfyve and Sac3 in a complex to promote PIKfyve activity and functionality.

Authors:  Diego Sbrissa; Ognian C Ikonomov; Homer Fenner; Assia Shisheva
Journal:  J Mol Biol       Date:  2008-10-11       Impact factor: 5.469

8.  YM201636, an inhibitor of retroviral budding and PIKfyve-catalyzed PtdIns(3,5)P2 synthesis, halts glucose entry by insulin in adipocytes.

Authors:  Ognian C Ikonomov; Diego Sbrissa; Assia Shisheva
Journal:  Biochem Biophys Res Commun       Date:  2009-03-14       Impact factor: 3.575

9.  Muscle-specific Pikfyve gene disruption causes glucose intolerance, insulin resistance, adiposity, and hyperinsulinemia but not muscle fiber-type switching.

Authors:  Ognian C Ikonomov; Diego Sbrissa; Khortnal Delvecchio; Han-Zhong Feng; Gregory D Cartee; Jian-Ping Jin; Assia Shisheva
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-05-14       Impact factor: 4.310

10.  Sac3 is an insulin-regulated phosphatidylinositol 3,5-bisphosphate phosphatase: gain in insulin responsiveness through Sac3 down-regulation in adipocytes.

Authors:  Ognian C Ikonomov; Diego Sbrissa; Takeshi Ijuin; Tadaomi Takenawa; Assia Shisheva
Journal:  J Biol Chem       Date:  2009-07-03       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.